(19)
(11) EP 1 869 214 A2

(12)

(88) Date of publication A3:
28.06.2007

(43) Date of publication:
26.12.2007 Bulletin 2007/52

(21) Application number: 06739311.6

(22) Date of filing: 22.03.2006
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
(86) International application number:
PCT/US2006/010464
(87) International publication number:
WO 2006/104812 (05.10.2006 Gazette 2006/40)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 25.03.2005 US 665168 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)
  • NOVARTIS-PHARMA GMBH
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • CHEN, Hong
    Newton, MA 02459 (US)
  • HUGHES, Thomas, Edward
    Concord, MA 01742 (US)

(74) Representative: Crawley, Patrick Edward 
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) BIOMARKERS FOR PHARMACOGENETIC DIAGNOSIS OF TYPE 2 DIABETES